RT Book, Section
A1 Qadan, Motaz
A1 Jarnagin, William R.
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145763831
T1 Hepatocellular Carcinoma
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK hemonc.mhmedical.com/content.aspx?aid=1145763831
RD 2024/04/19
AB Hepatocellular  carcinoma  (HCC)  is  the  fifth  most  common  cancer  globally  and  accounts  for  the  third  most  cancer  deaths  worldwide  (Fig.  127-1).  Although  geographic  variability  exists  in  the  incidence  of  the  disease,  occurring  less  commonly  in  the  United  States  and  Europe,  its  incidence  is  steadily  rising,  having  tripled  in  the  United  States  since  the  1970s  and  projected  to  increase  over  the  next  20  years  (Table  127-1).  The  current  incidence  of  HCC  in  the  Western  world  is  estimated  at  3%  to  4%  with  5-year  survival  estimated  to  be  16%  for  all-comers.1